The collaboration will further explore the scientific and clinical role of citrullinated proteins in the treatment of cancer. Scancell’s Moditope platform technology overcomes the immune suppression induced by
The two stage, open-label trial will evaluate the tolerability, safety, pharmacokinetics and activity of ADCT-402 in patients with relapsed or refractory B-NHL. The first stage is a dose
The Company anticipates the following events to occur over the coming months and will provide updates on its EU orphan designation progress as key milestones occur. In the
The FDA requested additional CMC information for the Multi-Dose Preservative-Free (MDPF) bottle, a first of its kind container with patented uni-directional valve and air filter technology. Allergan is
The shared goal is the identification and validation of novel druggable sites in disease pathways, and the development of a pipeline of novel therapeutic targets in the oncology
Under the contract, SRI Biosciences, a division of SRI International, will conduct preclinical studies to assess the efficacy of specific compounds or vaccines for preventing invasive-cancer development. Researchers
The Series B financing was provided by Hiroshi Mikitani through his personal investment companies. Hiroshi Mikitani is the CEO of Rakuten, Inc., one of the world’s leading internet
The Phase 1b portion of the study utilizes a basket design focusing on patients with solid tumors that contain molecular alterations of RET or BRAF. "We are excited
That’s why researchers at Hennepin County Medical Center (Minneapolis, Minn.) and the University of Minnesota are launching an innovative, comprehensive study in collaboration with Abbott (NYSE: ABT) to
The international syndicate was co-led by Versant Ventures and 5AM Ventures, with participation by Sectoral Asset Management. HealthCap acted as the local lead investor. Aprea’s main shareholder is
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.